GLP-1 drugs, formally called glucagon-like peptide-1 receptor agonists, are incretin-based therapies that activate the GLP-1 receptor
This improved safety profile may make Retatrutide a more appealing option for patients who are hesitant to take on the potential risks associated with certain traditional medications, particularly those with chronic or long-term conditions
Because when you have the right support team, this chapter of your life can be about thriving, not just surviving
While prescription GLP-1 drugs offer the most dramatic results and stimulant-based products deliver quick bursts of energy, ColonBroom fills the middle ground: accessible, safe for long-term use, and focused on gradual appetite control
These companies source their peptides from chemical manufacturers, often based in China
GIP Agonism: Does It Help or Hurt